| Defensins: The natural peptide antibiotic X Gao, J Ding, C Liao, J Xu, X Liu, W Lu Advanced drug delivery reviews 179, 114008, 2021 | 116 | 2021 |
| Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy M Liu, J Li, D Zhao, N Yan, H Zhang, M Liu, X Tang, Y Hu, J Ding, ... Biomaterials 283, 121415, 2022 | 43 | 2022 |
| Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy J Ding, D Sui, M Liu, Y Su, Y Wang, M Liu, X Luo, X Liu, Y Deng, Y Song Acta Biomaterialia 134, 702-715, 2021 | 42 | 2021 |
| Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights M Liu, Y Chu, H Liu, Y Su, Q Zhang, J Jiao, M Liu, J Ding, M Liu, Y Hu, ... Molecular pharmaceutics 17 (4), 1059-1070, 2019 | 36 | 2019 |
| Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy J Ding, D Zhao, Y Hu, M Liu, X Liao, B Zhao, X Liu, Y Deng, Y Song International Journal of Pharmaceutics 571, 118706, 2019 | 34 | 2019 |
| Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon Y Su, M Liu, Y Xiong, J Ding, X Liu, Y Song, Y Deng Drug Delivery and Translational Research 9, 66-75, 2019 | 23 | 2019 |
| Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity D Sui, X Tang, J Ding, Y Wang, Y Qin, N Zhang, X Liu, Y Deng, Y Song International Journal of Pharmaceutics 602, 120552, 2021 | 21 | 2021 |
| Redox-and pH-sensitive glycan (polysialic acid) derivatives and F127 mixed micelles for tumor-targeted drug delivery M Liu, X Luo, Q Qiu, L Kang, T Li, J Ding, Y Xiong, Z Zhao, J Zan, ... Molecular Pharmaceutics 15 (12), 5534-5545, 2018 | 21 | 2018 |
| A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions M Liu, Y Su, M Chen, J Wang, M Liu, Y Dai, C Wang, X Luo, C Lai, M Liu, ... Journal of Controlled Release 343, 657-671, 2022 | 19 | 2022 |
| Cryo-shocked cancer cells as an oncolytic adenovirus reservoir for glioblastoma immunotherapy X Liu, J Xu, T Yao, J Ding, S Li, R Su, H Zhang, H Li, Q Yue, X Gao ACS Applied Materials & Interfaces 15 (1), 67-76, 2022 | 16 | 2022 |
| Murine RAW264. 7 cells as cellular drug delivery carriers for tumor therapy: a good idea? H Zheng, J Li, X Luo, C Li, L Hu, Q Qiu, J Ding, Y Song, Y Deng Cancer Chemotherapy and Pharmacology 83, 361-374, 2019 | 16 | 2019 |
| Sialic acid-mediated photochemotherapy enhances infiltration of CD8+ T cells from tumor-draining lymph nodes into tumors of immunosenescent mice D Sui, C Li, X Tang, X Meng, J Ding, Q Yang, Z Qi, X Liu, Y Deng, Y Song Acta Pharmaceutica Sinica B 13 (1), 425-439, 2023 | 10 | 2023 |
| A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors M Liu, X Tang, J Ding, M Liu, B Zhao, Y Deng, Y Song Pharmaceutical Research 36, 1-12, 2019 | 9 | 2019 |
| The fate of sialic acid and PEG modified epirubicin liposomes in aged versus young cells and tumor mice models D Sui, X Meng, C Li, X Tang, Y Qin, N Zhang, J Ding, X Liu, Y Deng, ... Pharmaceutics 14 (3), 545, 2022 | 8 | 2022 |
| Virus‐mimetic systems for cancer diagnosis and therapy X Gao, J Ding, Q Long, C Zhan Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 13 (3 …, 2021 | 8 | 2021 |
| Enhancing the antitumor efficacy of oncolytic adenovirus through sonodynamic therapy-augmented virus replication J Ding, R Su, R Yang, J Xu, X Liu, T Yao, S Li, C Wang, H Zhang, Q Yue, ... ACS nano 18 (28), 18282-18298, 2024 | 2 | 2024 |
| Peptide-TLR7/8a-Coordinated DNA Vaccines Elicit Enhanced Immune Responses against Infectious Diseases R Yang, T Yao, J Xu, X Liu, Y Yang, J Ding, C Cao, R Su, S Li, W Lu, ... ACS Biomaterials Science & Engineering, 2024 | 2 | 2024 |
| Nanosynergist-engineered oncolytic adenovirus enhancing immune-virotherapy efficacy for glioblastoma via interrupting antiviral responses J Xu, X Liu, J Ding, H Zhang, T Yao, S Li, R Yang, N Yu, Q Yue, C Zhan, ... Nano Today 57, 102328, 2024 | 1 | 2024 |
| Article Title: Virus-mimetic Systems for Cancer Diagnosis and Therapy X Gao, J Ding, Q Long, C Zhan | | |
